Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

December 01, 2022; Volume 102,Issue 6

Articles

  • Structural Basis for the Allosteric Inhibition of Hypoxia-Inducible Factor 2 by Belzutifan
    You have access
    Structural Basis for the Allosteric Inhibition of Hypoxia-Inducible Factor 2 by Belzutifan
    Xintong Ren, Xiaotong Diao, Jingjing Zhuang and Dalei Wu
    Molecular Pharmacology December 2022, 102 (6) 240-247; DOI: https://doi.org/10.1124/molpharm.122.000525
  • You have access
    Cancer-Type Organic Anion Transporting Polypeptide 1B3 Is Localized in Lysosomes and Mediates Resistance against Kinase Inhibitors
    Bastian Haberkorn, Stefan Oswald, Niklas Kehl, Arne Gessner, R. Verena Taudte, Jan Philipp Dobert, Friederike Zunke, Martin F. Fromm and Jörg König
    Molecular Pharmacology December 2022, 102 (6) 248-258; DOI: https://doi.org/10.1124/molpharm.122.000539
  • You have access
    Differential Enantiomer-Specific Signaling of Cannabidiol at CB1 Receptors
    Taryn Bosquez-Berger, Sierra Wilson, Christos Iliopoulos-Tsoutsouvas, Shan Jiang, Jim Wager-Miller, Spyros P. Nikas, Ken P. Mackie, Alexandros Makriyannis and Alex Straiker
    Molecular Pharmacology December 2022, 102 (6) 259-268; DOI: https://doi.org/10.1124/molpharm.121.000305
  • Coincident Regulation of PLC<em>β</em> Signaling by Gq-Coupled and <em>μ</em>-Opioid Receptors Opposes Opioid-Mediated Antinociception
    You have access
    Coincident Regulation of PLCβ Signaling by Gq-Coupled and μ-Opioid Receptors Opposes Opioid-Mediated Antinociception
    Gissell A. Sanchez, Emily M. Jutkiewicz, Susan Ingram and Alan V. Smrcka
    Molecular Pharmacology December 2022, 102 (6) 269-279; DOI: https://doi.org/10.1124/molpharm.122.000541

Editorial

  • You have access
    A Sentimental Segue
    Molecular Pharmacology December 2022, 102 (6) 288-289; DOI: https://doi.org/10.1124/molpharm.122.000632
  • You have access
    Announcement
    Molecular Pharmacology December 2022, 102 (6) 291; DOI: https://doi.org/10.1124/molpharm.122.000635

Minireview

  • You have access
    Transcriptional Regulation, Signaling Pathways, and Subcellular Localization of Corticotropin-Releasing Factor Receptors in the Central Nervous System
    Paula Amado, Juan Zegers, Hector E. Yarur and Katia Gysling
    Molecular Pharmacology December 2022, 102 (6) 280-287; DOI: https://doi.org/10.1124/molpharm.121.000476

Erratum

  • You have access
    Correction to “Analgesic α-Conotoxin Binding Site on the Human GABAB Receptor”
    Molecular Pharmacology December 2022, 102 (6) 290; DOI: https://doi.org/10.1124/molpharm.122.000543err
Back to top
PreviousNext

In this issue

Molecular Pharmacology: 102 (6)
Molecular Pharmacology
Vol. 102, Issue 6
1 Dec 2022
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts

Jump to

  • Articles
  • Editorial
  • Minireview
  • Erratum
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics